Drugs / Amoxicillin/Clavulanate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00493038 Comparator | Feb 2006 → Jan 2008 | bacterial infectious disease, sinusitis | Bayer | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicillin/Clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00493038 ↗ |
| Known as | Amoxicilline/Clavulanate | “Patient will be administered daily Amoxicilline/Clavulanate 1000 mg tablets every 8 hours for 10 days” NCT00493038 ↗ |
| Route | Oral | “Patient will be administered daily Amoxicilline/Clavulanate 1000 mg tablets every 8 hours for 10 days” NCT00493038 ↗ |